ah 6809 has been researched along with pyrrolidonecarboxylic acid in 1 studies
| Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (pyrrolidonecarboxylic acid) | Trials (pyrrolidonecarboxylic acid) | Recent Studies (post-2010) (pyrrolidonecarboxylic acid) |
|---|---|---|---|---|---|
| 163 | 1 | 49 | 3,005 | 101 | 671 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hijikata, T; Ichikawa, H; Morimoto, Y; Takahashi, T; Tsuneyama, K | 1 |
1 other study(ies) available for ah 6809 and pyrrolidonecarboxylic acid
| Article | Year |
|---|---|
Inhibition of EP2/EP4 prostanoid receptor-mediated signaling suppresses IGF-1-induced proliferation of pancreatic cancer BxPC-3 cells via upregulating γ-glutamyl cyclotransferase expression.
Topics: Cell Line, Tumor; Cell Proliferation; gamma-Aminobutyric Acid; gamma-Glutamylcyclotransferase; Humans; Insulin-Like Growth Factor I; Isoindoles; Metabolome; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Sulfonamides; Up-Regulation; Xanthones | 2019 |